Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
12/02/1997 | US5693776 Nucleic acids specific for Rochalimaea quintana |
12/02/1997 | US5693775 Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use |
12/02/1997 | US5693774 DNA sequences involved in soraphen biosynthesis by myxobacteria |
12/02/1997 | US5693764 Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof as diagnostics and therapeutics |
12/02/1997 | US5693763 Antibodies to human carcinoma antigen |
12/02/1997 | US5693762 Humanized immunoglobulins |
12/02/1997 | US5693761 Genetic engineering; complementarity zones |
12/02/1997 | US5693757 Huntingtin DNA, protein and uses thereof |
12/02/1997 | US5693755 Construction and expression of synthetic genes encoding envelopes of human T cell leukemia virus type I |
12/02/1997 | US5693753 Method of isolating βA4 peptide species ending at carboxy-terminals residue 42 using monoclonal antibody 369.2B |
12/02/1997 | US5693752 Hexapeptides of specified amino acid sequences |
12/02/1997 | US5693536 Introducing wild-type mutated colorectal cancer gene into cell which has lost this function, then gene expression for antitumor activity |
12/02/1997 | US5693510 Genetically engineered fungus cells(ascomycetes) which produce reduced amounts of carboxypeptidase |
12/02/1997 | US5693506 Isolated dna sequence comprising transcriptional initiation region obtained from specified nucleic acid sequence |
12/02/1997 | US5693503 Process for preparation of amino acid |
12/02/1997 | US5693499 Plasmid comprising promoter dna, dna coding signal peptide, dna coding coagulation factor viii amino acid sequences, and termination codon; gene expression |
12/02/1997 | US5693497 Incubation of genetically engineered cells for gene expression of antigen which can be used for vaccines or diagnosis |
12/02/1997 | US5693496 DNA encoding the mouse and human PH30 beta chain protein |
12/02/1997 | US5693495 Allergens of alder pollen and applications thereof |
12/02/1997 | US5693492 Purified dna molecule encoding drosophila avermectin and/or glutamate binding protein which functions as glutamate-gated anion channel |
12/02/1997 | US5693491 Isolated and purified polynucleotide comprising nucleotide sequence encoding receptor having specified amino acid sequence |
12/02/1997 | US5693485 Enzymatic coupling reaction of N-protected-L-aspartic acid and phenylalanine methyl ester |
12/02/1997 | US5693478 Method of detecting amyloid precursor proteins |
11/27/1997 | WO1997044668A1 Early detection of lysosomal storage disorders |
11/27/1997 | WO1997044479A1 Novel antitumor compounds and process for producing the same |
11/27/1997 | WO1997044468A1 HUMAN INTERLEUKIN-1j AND ANTAGONISTS THEREOF |
11/27/1997 | WO1997044467A1 MITOGEN-ACTIVATED PROTEIN KINASE p38-2 AND METHODS OF USE THEREFOR |
11/27/1997 | WO1997044461A2 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
11/27/1997 | WO1997044460A1 Modulators of tissue regeneration |
11/27/1997 | WO1997044458A1 Kappa/mu-like protein tyrosine phosphatase, ptp lambda |
11/27/1997 | WO1997044457A1 Polycystic kidney disease gene |
11/27/1997 | WO1997044441A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
11/27/1997 | WO1997044440A1 Cell line |
11/27/1997 | WO1997044360A1 Novel human g-protein coupled receptor |
11/27/1997 | WO1997044359A1 Novel human g-protein coupled receptor |
11/27/1997 | WO1997044356A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH |
11/27/1997 | WO1997044058A1 Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same |
11/27/1997 | WO1997044052A1 Immunomodulating compounds comprising d-isomers of amino acids |
11/27/1997 | WO1997044000A2 Dna-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents |
11/27/1997 | WO1997035976A3 Epidermal differentiation factor |
11/27/1997 | DE19629938C1 Monoclonal antibodies specific for mutated E-Cadherin peptide sequences |
11/27/1997 | CA2731490A1 Early detection of lysosomal storage disorders |
11/27/1997 | CA2496906A1 Ret ligand (retl) for stimulating neural and renal growth |
11/27/1997 | CA2258698A1 Immunomodulating compounds comprising d-isomers of amino acids |
11/27/1997 | CA2256109A1 Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same |
11/27/1997 | CA2255906A1 Human interleukin-1j and antagonists thereof |
11/27/1997 | CA2255579A1 Mitogen-activated protein kinase p38-2 and methods of use therefor |
11/27/1997 | CA2254083A1 Polycystic kidney disease gene |
11/27/1997 | CA2253431A1 Kappa/mu-like protein tyrosine phosphatase, ptp lambda |
11/26/1997 | EP0808902A2 Novel genes encoding antiviral proteins of Phytolacca insularis Nakai and recombinant microorganisms expressing the same proteins |
11/26/1997 | EP0808901A2 Pharmaceutical preparation with factor VIII procoagulant activity and vWF-binding activity |
11/26/1997 | EP0808900A2 Polynucleotides and polypeptides associated with benign prostatic hypertrophy |
11/26/1997 | EP0808899A2 Human marco scavenger receptor (HMarcoSR) |
11/26/1997 | EP0808897A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
11/26/1997 | EP0808369A1 GnRH-LEUKOTOXIN CHIMERAS |
11/26/1997 | EP0808365A1 Human interleukin-1 receptor accessory protein |
11/26/1997 | EP0808364A1 Human pancreatic cell lines: developments and uses |
11/26/1997 | EP0808351A2 Cytoplasmic antiproteinase-2 and cytoplasmic antiproteinase-3 and coding sequences |
11/26/1997 | EP0808323A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF |
11/26/1997 | EP0808169A1 Programmed cell death genes and proteins |
11/26/1997 | EP0662130B1 A method of producing hepatocyte growth factor and a cell line |
11/26/1997 | EP0580829B1 Bacterial protein extract, process for preparing the same and pharmaceutical composition containing said extract |
11/26/1997 | EP0542863B1 Expression of recombinant polypeptides with improved purification |
11/26/1997 | EP0482176B1 Monoclonal antibodies specific for toxin b of clostridium difficile |
11/26/1997 | CN1166183A Calcium free subtilisin mutants |
11/26/1997 | CN1166182A D-pantolactone hydrolase and gene encoding the same |
11/26/1997 | CN1036532C Process for preparing non-glycosylated recombining human IL2 in reduced form |
11/25/1997 | US5691449 Respiratory syncytial virus vaccines |
11/25/1997 | US5691448 Glutamic acid decarboxylase protein for autoantibody binding to epitopes |
11/25/1997 | US5691447 GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies |
11/25/1997 | US5691308 Polypeptide insecticide |
11/25/1997 | US5691188 Genetic engineering |
11/25/1997 | US5691186 Filariid cysteine protease genes |
11/25/1997 | US5691169 Process for preparing a desired protein |
11/25/1997 | US5691168 DNA sequences encoding AlaGlu-IGF-1 and vectors and microorganisms comprising said sequences |
11/25/1997 | US5691167 DNA encoding allergenic proteins and peptides from Johnson grass pollen |
11/25/1997 | US5691165 Hydrolysis using protease, deactivation and separation |
11/25/1997 | US5691163 Cells with altered betaine catabolism and their use in producing metabolites or enzymes |
11/25/1997 | US5691155 Detectors, vectors, gene expression |
11/25/1997 | US5691152 Stable avidin composition |
11/25/1997 | US5690929 Use of methioninase and chemotherapy agents in chemotherapy |
11/25/1997 | US5690928 Administering transforming growth factor |
11/25/1997 | CA2099865C Hepatic growth factor receptor is the met proto-oncogene |
11/24/1997 | CA2205824A1 Pharmaceutical preparation with factor viii procoagulant activity and vwf binding activity |
11/23/1997 | CA2186303A1 Novel genes encoding antiviral proteins of phytolacca insularis nakai and recombinant microorganisms expressing the same proteins |
11/20/1997 | WO1997043650A1 Method and reagent for monitoring blood levels of antiplatelet compounds |
11/20/1997 | WO1997043649A1 CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrP?sc¿ |
11/20/1997 | WO1997043647A1 Dp and e2f protein nuclear localisation signals and their use |
11/20/1997 | WO1997043436A1 A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium |
11/20/1997 | WO1997043418A1 Globulin protein 11s, usable as a seed impregnation marker during germination. |
11/20/1997 | WO1997043412A1 Novel agouti-related gene |
11/20/1997 | WO1997043408A1 Anti-human mp52 monoclonal antibody |
11/20/1997 | WO1997043315A1 NOVEL MONOCLONAL ANTIBODY AND METHOD OF IMMUNOLOGICAL ANALYSIS OF e-D DIMER AND e-DD/E COMPLEX |
11/20/1997 | WO1997043314A2 Collagen binding protein compositions and methods of use |
11/20/1997 | WO1997043311A1 Anticoagulant peptide fragments derived from apolipoprotein b-100 |
11/20/1997 | WO1997043306A1 Neuroactive peptides |
11/20/1997 | WO1997043304A1 Novel compounds |
11/20/1997 | WO1997043303A1 Novel compounds |
11/20/1997 | WO1997043302A1 Acyl transfer with stabilised transition complex using catalyst with catalytic imidazole (e.g. histidine) function |
11/20/1997 | WO1997042971A1 Recombinant neospora antigens and their uses |